Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
60 participants
INTERVENTIONAL
2018-08-15
2019-12-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Platelet Rich Plasma in the Prevention of Adhesion Reformation
NCT06608407
Platelet-rich Plasma (PRP) for Endometrial Regeneration and Repair
NCT02825849
The Efficacy of G-CSF Against Adhesion Reformation After Hysteroscopic Adhesiolysis
NCT02855632
Use of PRP in Endometrial Reconstruction
NCT03249415
Role of Chronic Endometritis in Postoperative Recurrence of Severe Intrauterine Adhesions
NCT02744807
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
2. Study design:prospective, randomized controlled cohort study, patients with intrauterine adhesions were randomized into two groups, the control group and the intervention group (intraoperative and postoperative 1 week postoperative PRP). The surgical procedures and postoperative medication regimens were the same.
3. Compare the biochemical pregnancy rate, clinical pregnancy rate, abortion rate and live birth rate after hysteroscopic resection in PRP group and control group, and explore the effect of PRP on pregnancy outcome after intrauterine adhesion.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
SINGLE_GROUP
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
PRP
Platelet-rich plasma
Platelet-rich plasma
Platelet-rich plasma intrauterine injection
Gel
Self-crosslinking sodium hyaluronate gel
gel
Self-crosslinking sodium hyaluronate gel intrauterine injection
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Platelet-rich plasma
Platelet-rich plasma intrauterine injection
gel
Self-crosslinking sodium hyaluronate gel intrauterine injection
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Exclusion Criteria
20 Years
37 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Yanhong Deng
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Yanhong Deng
professor
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RPR-IUAs
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.